Found: 5
Select item for more details and to access through your institution.
Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.
- Published in:
- Molecular Psychiatry, 2009, v. 14, n. 3, p. 269, doi. 10.1038/sj.mp.4002130
- By:
- Publication type:
- Article
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues.
- Published in:
- Molecular Psychiatry, 2008, v. 13, n. 12, p. 1118, doi. 10.1038/sj.mp.4002108
- By:
- Publication type:
- Article
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 7, p. 643, doi. 10.1038/sj.mp.4001532
- By:
- Publication type:
- Article
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 7, p. 684, doi. 10.1038/sj.mp.4001511
- By:
- Publication type:
- Article
Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.
- Published in:
- British Journal of Cancer, 2014, v. 110, n. 6, p. 1622, doi. 10.1038/bjc.2014.24
- By:
- Publication type:
- Article